These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3765712)

  • 21. [Immune reactivity of patients with pulmonary tuberculosis suffering from chronic alcoholism].
    Mel'nik VP
    Vrach Delo; 1989 Apr; (4):82-5. PubMed ID: 2787943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of patients with pulmonary tuberculosis with antitubercular preparations and levamisole].
    Feuereisl R; Papezová E
    Probl Tuberk; 1988; (3):31-3. PubMed ID: 3290887
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effectiveness of administration of thymalin in the complex treatment of pulmonary tuberculosis].
    Kogosova LS; Chernushenko EF; Il'nitskiĭ IG; Goncharova SI; Markov AE; Kuchugura-Kucherenko LV
    Probl Tuberk; 1990; (10):29-32. PubMed ID: 2080155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dynamics of the immunological indices during the treatment of pulmonary tuberculosis patients suffering from chronic alcoholism].
    Kulakov SV
    Vrach Delo; 1986 Feb; (2):77-9. PubMed ID: 3705576
    [No Abstract]   [Full Text] [Related]  

  • 25. [Neutrophil chemotactic activity in syphilis patients during treatment].
    Borisenko KK; Lezvinskaia EM; Basinskaia NM; Mikheev NA
    Vestn Dermatol Venerol; 1985 Apr; (4):57-9. PubMed ID: 4002850
    [No Abstract]   [Full Text] [Related]  

  • 26. Trial of immunopotentiation by levamisole in patients with pulmonary tuberculosis.
    Yaseen NY; Thewaini AJ; Al-Tawil NG; Jazrawi FY
    J Infect; 1980 Jun; 2(2):125-36. PubMed ID: 6985257
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunologic changes and their correction in different forms of acute cholecystitis in late middle-age and the aged].
    Zatevakhin II; Krylov LB; Mamatkulov SM; Sabirov BU; Akhtamov DA
    Khirurgiia (Mosk); 1985 Feb; (2):84-7. PubMed ID: 3981944
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunity of middle age and aged patients with tuberculosis and its changes during multimodality treatment by using T-activin].
    Adambekov DA; Litvinov VI; Mambetov KB; Koshmuratov AG; Sabyrbekova TS
    Probl Tuberk; 1998; (5):46-8. PubMed ID: 9866400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracorporeal immunopharmacotherapy in patients with chronic septic cholangitis.
    Khaitov RM; Galperin EI; Podobin NP; Leskov VP; Fedenko ES; Prosorovsky NS; Akhaladze GG; Prokopenko VP
    Hepatogastroenterology; 1993 Apr; 40(2):126-30. PubMed ID: 8509042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diucifon in the treatment of chronic aphthous stomatitis].
    Terekhova NV; Lialina MI; Khazanova VV; Zemskaia EA; Zidra SI
    Stomatologiia (Mosk); 1986; 65(1):20-1. PubMed ID: 3456657
    [No Abstract]   [Full Text] [Related]  

  • 31. [Mumie as a pathogenetic agent in the treatment of tuberculosis].
    Agzamov RA; Arifkhanova SI; Vakhidova GA
    Probl Tuberk; 1988; (7):49-52. PubMed ID: 3265209
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of side effects of specific chemotherapy in patients with pulmonary tuberculosis].
    Batian AN; Abramovskaia AK; Batian ON
    Probl Tuberk; 1991; (7):60-2. PubMed ID: 1754594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A trial of the use of the new Russian preparation oxymetacil in patients with chronic nonspecific lung diseases].
    Borisova AM
    Ter Arkh; 1995; 67(3):20-2. PubMed ID: 7770795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of myelopid in the complex treatment of patients with destructive pulmonary tuberculosis].
    Vakhidova GA; Vasil'eva FR; Kurbanova RR; Stepanenko RN; Ubaĭdullaev AM
    Probl Tuberk; 1990; (3):16-8. PubMed ID: 2367502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Possible use of diucifon in true eczema].
    Kubanova AA; Vadil'eva LL; Petrova IV; Leshchenko GM
    Vestn Dermatol Venerol; 1983 Dec; (12):24-6. PubMed ID: 6369823
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effectiveness of antitubercular chemotherapy combined with corticosteroids and immunomodulators].
    Khomenko IS; Chukanov VI; Gergert VIa; Utkin VV
    Probl Tuberk; 1990; (1):24-8. PubMed ID: 2336431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinico-immunological criteria of the effectiveness of chemotherapy in patients with destructive pulmonary tuberculosis].
    Ivaniuta OM; Kogosova LS; Il'nitskiĭ IG; Zamdborg IuL; Davyda RS
    Probl Tuberk; 1986; (2):42-5. PubMed ID: 3703842
    [No Abstract]   [Full Text] [Related]  

  • 38. [Chemotherapy-induced lung functional changes in patients with destructive pulmonary tuberculosis].
    Nefedov VB; Smirnova DG
    Probl Tuberk; 1996; (6):60-3. PubMed ID: 9019776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Specific features of diagnosis and treatment of patients with pulmonary sarcoidosis and tuberculosis].
    Kostina ZI; Brazhenko NA; Gerasimova EV; Kol'nikova OV
    Probl Tuberk; 1998; (2):10-3. PubMed ID: 9613175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Laser and chemotherapy and the immune status of patients with fibrous-cavernous tuberculosis].
    Sergeeva LV; Dobkin VG; Markov AN
    Probl Tuberk; 1996; (1):22-4. PubMed ID: 8907479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.